GALNT2 and obesity disorder: Taken altogether, the data that we have reported here are quite consistent with the contribution of GALNT2 to several highly prevalent metabolic abnormalities sharing the common ground of insulin resistance, namely atherogenic dyslipidemia, type 2 diabetes and obesity.